Search Results - thomas+graeber

2 Results

Sort By:

2019-479 IDENTIFICATION OF PAN-CANCER SMALL CELL NEUROENDOCRINE PHENOTYPES AND VULNERABILITIES

SummaryUCLA researchers in the Department of Molecular and Medical Pharmacology have developed a classifier for the identification and treatment of small cell neuroendocrine cancers and small-round-blue cell tumors not previously identified.BackgroundSmall cell neuroendocrine (SCN) cancers are an extremely aggressive cancer type that arise across many...

Published: 7/19/2023 | Inventor(s): Thomas Graeber

Keywords(s): Diagnostic Markers & Platforms, Diagnostic Platform Technologies (E.G. Microfluidics), Oncology

Category(s): Diagnostic Markers, Platforms > Diagnostic Platform Technologies, Therapeutics > Oncology > Oncology (Small Molecules)

Treatment Of Melanoma With Ferroptosis Inducing Agents

Case 2017-879UCLA researchers in the Departments of Molecular and Medical Pharmacology and Medicine have developed a novel method to treat melanoma.BACKGROUNDImmune checkpoint blockade immunotherapy with anti-PD1 antibody is the preferred treatment for patients with metastatic melanoma that has resisted other therapies. However, there remains a subset...

Published: 4/25/2024 | Inventor(s): Thomas Graeber, Antoni Ribas, Nicolaos Palaskas, Lidia Robert, Jennifer Tsoi

Keywords(s):

Category(s): Therapeutics > Oncology